Learn more

SQUIBB & SONS LLC

Overview
  • Total Patents
    170
  • GoodIP Patent Rank
    32,574
  • Filing trend
    ⇩ 16.0%
About

SQUIBB & SONS LLC has a total of 170 patent applications. It decreased the IP activity by 16.0%. Its first patent ever was published in 2000. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are MEDAREX INC, NOVIMMUNE SA and IMCLONE SYSTEMS INC.

Patent filings in countries

World map showing SQUIBB & SONS LLCs patent filings in countries
# Country Total Patents
#1 United States 42
#2 Australia 39
#3 EPO (European Patent Office) 28
#4 Hungary 14
#5 Israel 11
#6 Hong Kong 6
#7 Chile 5
#8 Serbia 5
#9 South Africa 5
#10 Montenegro 3
#11 Norway 3
#12 Canada 2
#13 Republic of Korea 2
#14 Belgium 1
#15 Brazil 1
#16 China 1
#17 Slovenia 1
#18 Taiwan 1

Patent filings per year

Chart showing SQUIBB & SONS LLCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Korman Alan J 54
#2 Cardarelli Josephine M 48
#3 Huang Haichun 48
#4 Srinivasan Mohan 38
#5 Selby Mark J 34
#6 Wang Changyu 31
#7 Yamanaka Mark 30
#8 Witte Alison 24
#9 Zens Kyra D 21
#10 Leblanc Heidi 21

Latest patents

Publication Filing date Title
AU2013257387A1 Monoclonal antibodies against glypican-3
AU2012241084A1 Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1
AU2012203451A1 Interferon alpha antibodies and their uses
ZA201200733B Antiproliferative compounds,conjugates thereof,methods therefor,and uses thereof
AU2011250741A1 IP-10 antibodies and their uses
AU2011236019A1 Interferon alpha receptor 1 antibodies and their uses
AU2011203119A1 Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
EP3431608A2 Method for enhanced protein production
EP2403878A1 Fully human antibodies specific to cadm1
AU2008284271A1 Matriptase protein and uses thereof
HUE028737T2 Monoclonal antibodies against glypican-3
TW200831535A Human antibodies that bind cxcr4 and uses thereof
AU2007203559A1 Compositions and methods for the therapy of inflammatory bowel disease
AU2007235496A1 Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
AU2006321553A1 Human monoclonal antibodies to O8E
CA3018525A1 Human monoclonal antibodies to programmed death ligand 1 (pd-l1)
AU2006214032A1 Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residues
HUE035520T2 Interferon alpha antibodies and their uses
AU2004270103A1 Human monoclonal antibodies against Bacillusanthracis protective antigen